Shijiazhuang No.4 Pharmaceutical Group (02005): Low-calcium peritoneal dialysis solution (bicarbonate G1.5%) and other drugs obtained drug production registration approval
Zhitong Finance APP news, Shijiazhuang No.4 Pharmaceutical Group (02005) issued an announcement that the group has obtained drug production registration approvals from China's National Medical Products Administration (NMPA) for low-calcium peritoneal dialysis solution (bicarbonate-G1.5%), peritoneal dialysis solution (bicarbonate-G2.5%), peritoneal dialysis solution (bicarbonate-G4.25%), and low-calcium peritoneal dialysis solution (bicarbonate-G4.25%) (the Products), all in 2000ml specifications, belonging to Class 3 chemical drugs, and deemed to have passed consistency evaluation, among which low-calcium peritoneal dialysis solution (bicarbonate-G4.25%) is the third approved among domestic enterprises. The Products are mainly used for peritoneal dialysis in patients with chronic renal failure, and are used when hypermagnesemia has not been sufficiently improved.
Latest
12 m ago

